EUVIMEDEUVIMED entdecken
Crossref

Molecular Changes in CSPG and Glial Scar Markers in Response to Subpial Chondroitinase ABC Treatment Following Spinal Cord Injury

Alexandra Kisucká iD, Katarína Kiss Bimbová, Tomáš Kuruc, Mária Ileninová, Karolína Kuchárová iD, Lenka Ihnátová, Mária Bačová, Martina Magurová, Ján Gálik, Nadežda Lukáčová iD

European Journal of Neuroscience · 2026

DOI: 10.1111/ejn.70389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, 2026. Verfasst von Alexandra Kisucká und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neurobiology of Biomedical Research Center, Slovak Academy of Sciences, Košice, Slovakia. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Chondroitin ABC Lyase, Chondroitin Sulfate Proteoglycans, Neuroglia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences, Bilateral Mobility Projects, Agentúra na Podporu Výskumu a Vývoja.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chondroitin sulphate proteoglycans (CSPGs) are major contributors to the inhibitory microenvironment that hinders regeneration following spinal cord injury (SCI). Chondroitinase ABC (ChABC) mediated degradation of CSPGs is associated with enhanced regenerative potential following SCI. In this study, the molecular responses of Neurocan, NG2 and Phosphacan CSPGs, as well as cellular markers for pro‐inflammatory and neuroprotective microglia, astrocytes, oligodendrocytes and neurons, were investigated following a single subpial injection of ChABC (0.2 U in 10 μL) 14 days after thoracic (Th9) spinal cord compression in adult Wistar rats. qRT‐PCR of samples from the lesion epicentre and adjacent cranial and caudal segments, 1 and 7 days after treatment, show that ChABC significantly suppressed Neurocan, NG2 and Phosphacan gene expression and reduced astrocytic (GFAP, S100B) and microglial/macrophage (Iba1, Cx3Cr1) reactivity after 24 h. Although most markers recovered within a week of ChABC delivery, sustained increases were observed for GAP‐43, particularly in cranial and caudal segments, suggesting the potential regenerative benefits of ChABC. Correlation analyses revealed region‐specific interactions between CSPG expression and glial phenotypes. Phosphacan displayed the strongest positive correlation with pro‐inflammatory microglial/macrophage markers (IL‐1β, iNOS) and the weakest with neuroprotective markers, suggesting a significant pro‐inflammatory role. NG2 was associated with both pro‐ and anti‐inflammatory markers, indicating a more balanced modulatory role, while Neurocan exhibited stronger correlations with neuroprotective markers. These findings highlight the importance of spatial and temporal context for SCI regenerative therapies targeting glial scar responses and support the therapeutic potential of subpial ChABC delivery for modifying the anti‐regenerative inhibitory microenvironment following SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesChondroitin ABC LyaseChondroitin Sulfate ProteoglycansNeurogliaCicatrixAnimalsProteoglycansChondroitin Sulfate Proteoglycan 4Rats, WistarAntigensRatsMicrogliaAstrocytesFemaleNeurocanMaleNeuronsVersicans

Stichwörter der Autor:innen

Chondroitinase ABCchondroitin sulphate proteoglycansglial scarspinal cord injurysubpial delivery

Substanzen

Chondroitin ABC LyaseChondroitin Sulfate ProteoglycansProteoglycansChondroitin Sulfate Proteoglycan 4AntigensNeurocanNcan protein, ratVcan protein, ratVersicans

Autor:innen und Institutionen

  • Institute of Neurobiology of Biomedical Research Center, Slovak Academy of Sciences, Košice, Slovakia.

ORCID-Profile: Alexandra Kisucká, Karolína Kuchárová, Nadežda Lukáčová

Förderung

  • Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences
  • Bilateral Mobility Projects
  • Agentúra na Podporu Výskumu a Vývoja

Zitieren

APA

Kisucká, A., Bimbová, K. K., Kuruc, T., Ileninová, M., Kuchárová, K., Ihnátová, L., Bačová, M., Magurová, M., Gálik, J., & Lukáčová, N. (2026). Molecular Changes in CSPG and Glial Scar Markers in Response to Subpial Chondroitinase ABC Treatment Following Spinal Cord Injury. European Journal of Neuroscience. https://doi.org/10.1111/ejn.70389

Vancouver

Kisucká A, Bimbová KK, Kuruc T, Ileninová M, Kuchárová K, Ihnátová L, et al. Molecular Changes in CSPG and Glial Scar Markers in Response to Subpial Chondroitinase ABC Treatment Following Spinal Cord Injury. European Journal of Neuroscience. 2026. doi:10.1111/ejn.70389

BibTeX
@article{Kisuck2026,
  author = {Kisucká, Alexandra and Bimbová, Katarína Kiss and Kuruc, Tomáš and Ileninová, Mária and Kuchárová, Karolína and Ihnátová, Lenka and Bačová, Mária and Magurová, Martina and Gálik, Ján and Lukáčová, Nadežda},
  title = {Molecular Changes in CSPG and Glial Scar Markers in Response to Subpial Chondroitinase ABC Treatment Following Spinal Cord Injury},
  journal = {European Journal of Neuroscience},
  year = {2026},
  doi = {10.1111/ejn.70389}
}
Kostenlos starten →